Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (321-330 of 538) with videos related to

Pageof 54
Sort By:
Atherosclerosis|April 1, 1991
Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cellsA Barkia, P Puchois, N Ghalim, et al.
The American Journal of Clinical Nutrition|April 1, 1997
Circadian variation of postprandial lipemiaM Romon, C Le Fur, P Lebel, et al.
American Journal of Nephrology|January 1, 1996
Neutral-lipid transfers and cholesteryl ester transfer protein in hemodialyzed patientsV Reade, H Mezdour, R Reade, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1977
[Exact determination of the lecithin/sphingomyelin ratio in amniotic fluid. Suggestion of a reference methods (author's transl)]J C Fruchart, A Ponthieu, N Porchet, et al.
The American Journal of Medicine|November 27, 1987
Effect of fenofibrate treatment on type III hyperlipoproteinemiaJ C Fruchart, J Davignon, J M Bard, et al.
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Lipids|April 3, 1999
Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the ratG Asset, B Staels, R L Wolff, et al.
The Journal of Clinical Investigation|August 1, 1995
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorN Vu-Dac, K Schoonjans, V Kosykh, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Pageof 54

Showing results (321-330 of 538) with videos related to

Sort By:
Pageof 54
Atherosclerosis|April 1, 1991
Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cellsA Barkia, P Puchois, N Ghalim, et al.
The American Journal of Clinical Nutrition|April 1, 1997
Circadian variation of postprandial lipemiaM Romon, C Le Fur, P Lebel, et al.
American Journal of Nephrology|January 1, 1996
Neutral-lipid transfers and cholesteryl ester transfer protein in hemodialyzed patientsV Reade, H Mezdour, R Reade, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1977
[Exact determination of the lecithin/sphingomyelin ratio in amniotic fluid. Suggestion of a reference methods (author's transl)]J C Fruchart, A Ponthieu, N Porchet, et al.
The American Journal of Medicine|November 27, 1987
Effect of fenofibrate treatment on type III hyperlipoproteinemiaJ C Fruchart, J Davignon, J M Bard, et al.
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Lipids|April 3, 1999
Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the ratG Asset, B Staels, R L Wolff, et al.
The Journal of Clinical Investigation|August 1, 1995
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorN Vu-Dac, K Schoonjans, V Kosykh, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Pageof 54